ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.
Saved in:
| Title: | ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells. |
|---|---|
| Authors: | Chan TS; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taiwan.; School of Medicine, College of Medicine, Taipei Medical University, Taiwan.; Pancreatic Cancer Group, Taipei Cancer Center, Taipei Medical University, Taiwan., Cheng LH; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan.; Core Laboratory of Organoids Technology, Office of R&D, Taipei Medical University, Taiwan., Hsu CC; School of Medicine, College of Medicine, I-Shou University, Kaohsiung City, Taiwan., Yang PM; Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taiwan., Liao TY; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan., Hsieh HY; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan., Lin PC; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan., HuangFu WC; Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taiwan., Chuu CP; Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan., Tsai KK; Laboratory of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taiwan.; Pancreatic Cancer Group, Taipei Cancer Center, Taipei Medical University, Taiwan.; Core Laboratory of Organoids Technology, Office of R&D, Taipei Medical University, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taiwan. |
| Source: | Molecular oncology [Mol Oncol] 2024 Mar; Vol. 18 (3), pp. 562-579. Date of Electronic Publication: 2024 Jan 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.13589 |
